Literature DB >> 22498380

Surgeon volume trumps specialty: outcomes from 3596 pediatric cholecystectomies.

Kesi Chen1, Kevin Cheung, Julie A Sosa.   

Abstract

BACKGROUND: Laparoscopic cholecystectomy is the standard surgical management of biliary disease in children, but there has been a paucity of studies addressing outcomes after pediatric cholecystectomies, particularly on a national level. We conducted the first study to address the effect of surgeon specialty and volume on clinical and economic outcomes after pediatric cholecystectomies on a population level.
METHODS: We conducted a retrospective cross-sectional study using the Health Care Utilization Project Nationwide Inpatient Sample. Children (≤ 17 years) who underwent laparoscopic cholecystectomy from 2003 to 2007 were selected. Pediatric surgeons performed 90% or higher of their total cases in children. High-volume surgeons were in the top tertile (n ≥ 37 per year) of total cholecystectomies performed. χ(2), Analyses of variance, and multivariate linear and logistic regression analyses were used to assess in-hospital complications, median length of hospital stay (LOS), and total hospital costs (2007 dollars).
RESULTS: A total of 3596 pediatric cholecystectomies were included. Low-volume surgeons had more complications, longer LOS, and higher costs than high-volume surgeons. After adjustment in multivariate regression, surgeon volume, but not specialty, was an independent predictor of LOS and cost.
CONCLUSIONS: High-volume surgeons have better outcomes after pediatric cholecystectomy than low-volume surgeons. To optimize outcomes in children after cholecystectomy, surgeon volume and laparoscopic experience should be considered above surgeon specialty.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22498380     DOI: 10.1016/j.jpedsurg.2011.10.054

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  7 in total

1.  Observations on Surgeons' Case Selection, Morbidity, and Mortality Following Board Certification.

Authors:  Christopher A Guidry; Timothy E Newhook; Florence E Turrentine; Min-Woong Sohn; Robert G Sawyer; R Scott Jones
Journal:  Ann Surg       Date:  2016-03       Impact factor: 12.969

2.  The Integration of Adult Acute Care Surgeons into Pediatric Surgical Care Models Supplements the Workforce without Compromising Quality of Care.

Authors:  Rudy J Judhan; Raquel Silhy; Kristen Statler; Mija Khan; Benjamin Dyer; Stephanie Thompson; Bryan Richmond
Journal:  Am Surg       Date:  2015-09       Impact factor: 0.688

3.  Comparative analysis of reliability and clinical effects of the critical view of safety approach used in laparoscopic cholecystectomy in the pediatric population.

Authors:  Şeref Selçuk Kılıç; Önder Özden; Selcan Türker Çolak
Journal:  Pediatr Surg Int       Date:  2021-02-14       Impact factor: 1.827

4.  Factors Associated With Outcomes and Costs After Pediatric Laparoscopic Cholecystectomy.

Authors:  Gileh-Gol Akhtar-Danesh; Aristithes G Doumouras; Cecily Bos; Helene Flageole; Dennis Hong
Journal:  JAMA Surg       Date:  2018-06-01       Impact factor: 14.766

5.  Total Abdominal Colectomies With Proctectomy Are Associated With Higher 30-Day Readmission Rates in Children With Ulcerative Colitis.

Authors:  Matthew D Egberg; Michael Phillips; Joseph A Galanko; Michael Kappelman
Journal:  Inflamm Bowel Dis       Date:  2021-03-15       Impact factor: 5.325

6.  Hypertrophic pyloric stenosis in the Maritimes: examining the waves of change over time.

Authors:  Alexander C Ednie; Ofer Amram; Jenna Colleen Creaser; Nadine Schuurman; Suzanne Leclerc; Natalie Yanchar
Journal:  Can J Surg       Date:  2016-12       Impact factor: 2.089

7.  The Right Child/Right Surgeon initiative: A position statement on pediatric surgical training, sub-specialization, and continuous certification from the American Pediatric Surgical Association.

Authors:  Samuel M Alaish; David M Powell; John H T Waldhausen; Stephen P Dunn
Journal:  J Pediatr Surg       Date:  2020-08-13       Impact factor: 2.545

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.